Why is Estradiol used to treat hair loss in women and transgender people undergoing hormone therapy?

Hair loss, especially when linked to hormonal changes, raises important questions about treatment options. Among these, estradiol—one of the most active forms of estrogen—has been used in specific contexts involving women and transgender individuals. But is this hormone genuinely effective for preserving or restoring hair?

And if so, what does science really say about its role in the body, specifically at the level of the hair follicle? This article critically examines these questions based on peer-reviewed evidence.

Hormonal Hair Loss: How Testosterone Can Trigger Thinning

Hair follicles react to the presence of certain hormones. The group most relevant in hair loss are androgens, which include testosterone and its more potent derivative, dihydrotestosterone (DHT). DHT can bind to receptors in the hair follicle and, over time, cause it to shrink—a process called miniaturization. This leads to finer hair and, eventually, to the cessation of hair production altogether.

In women, conditions like menopause or polycystic ovary syndrome (PCOS) disrupt the estrogen-androgen balance. When estrogen levels decline and androgen levels remain high or increase, DHT can act more freely on the scalp. This same mechanism is involved in transgender women transitioning with hormone therapy. To promote typically feminine characteristics, testosterone levels are intentionally lowered, and estradiol is introduced to simulate a more female-typical hormonal profile. The working hypothesis is that estradiol not only reduces circulating testosterone, but also provides direct support to the health and longevity of hair follicles. But to evaluate whether this is more than a theoretical benefit, we must examine the research.

Do Estrogens Like Estradiol Really Help Hair Follicles?

Laboratory work shows that scalp hair follicles can respond to estrogen. A 2003 study of human scalp skin found that estrogen receptor beta (ERβ) is the main estrogen receptor there, including in several parts of the hair follicle (Thornton et al., 2003). This shows where estrogen can act. It does not show that taking estradiol keeps or regrows hair.

Estradiol in Hormone Replacement Therapy (HRT): Observations from Menopause

Among postmenopausal women, hair thinning is a common complaint. Estradiol, used in hormone replacement therapy, has been investigated as a possible modulator of this condition. There are no good-quality trials of estradiol for hair loss in postmenopausal women. A 2012 summary of a Cochrane systematic review of treatments for female pattern hair loss found convincing evidence of benefit only for minoxidil (van Zuuren et al., 2012). In a 2025 randomised trial in 43 women, adding a topical estrogen (17α-ethinylestradiol 0.01%) to minoxidil gave no statistically significant advantage over minoxidil alone, and more women in the estrogen group had menstrual irregularities (Bedair et al., 2025).

What Happens When Estradiol Is Part of Gender-Affirming Therapy?

In transgender women, estradiol is prescribed in combination with androgen blockers like spironolactone or cyproterone acetate. The primary goal is to lower testosterone to female-typical levels while introducing estrogen to support feminization. But how does this hormonal balance affect the scalp and hair?

Published evidence on hair in trans women is very limited. One case report describes a transgender woman whose scalp hair regrew after about six months of oral estradiol and spironolactone, once her testosterone was in the female range (Stevenson et al., 2016). This is a single case. It cannot show how often this happens, and it cannot separate the effect of estradiol from the effect of lowering testosterone.

Can Estradiol Reverse Baldness or Only Slow It Down?

Evidence that estrogen regrows hair is weak. It is not known whether estradiol can bring back follicles that have already shrunk. There are no strong randomised trials of estradiol for hair loss, and none has compared it with standard treatments such as minoxidil.

What Are the Risks and What Should You Consider?

Estradiol is a systemic hormone. It affects the entire body, not just the hair. US estrogen labels carry a boxed warning. Estrogens increase the risk of endometrial cancer (a progestogen is needed in anyone with a uterus), and large trials reported higher risks of heart attack, stroke, blood clots, breast cancer and probable dementia (estradiol prescribing information, DailyMed). The label says estrogen must not be used by people with known, suspected or past breast cancer, other estrogen-dependent cancer, or a history of blood clots. Anyone with such a history should not use estradiol in any form unless their oncologist or specialist approves. Estradiol is not approved for treating hair loss. It is not a hair-loss treatment for men: in men it causes breast growth and other feminizing changes, some of which may not reverse, and it can reduce fertility. Estradiol gels and sprays can also pass to children and pets through skin contact; the US label for one estradiol spray (Evamist) reports breast budding in young girls and breast enlargement in young boys after such contact. This makes it essential to approach estradiol as part of a supervised medical plan—not a standalone treatment for hair loss. In both postmenopausal women and transgender individuals, estradiol’s contribution to hair health is best viewed as one piece of a larger hormonal puzzle. It is sometimes used alongside other hair-loss treatments, but it has not been shown to add to them: in the one randomised trial of a topical estrogen added to minoxidil (43 women, 6 months), the combination gave no statistically significant advantage (Bedair et al., 2025). Expecting dramatic regrowth is not supported by the current evidence.

What Do We Need to Know If We're Facing This Ourselves?

If you are considering estradiol to address hair loss due to hormonal changes, it’s important to ask a few key questions: **What is causing the hair loss—low estrogen, high testosterone, or something else entirely? Are other treatments being used that might interact with estradiol? **

And perhaps most importantly, are the benefits of hormonal intervention worth the systemic risks?

While estradiol might slow hair loss or improve the quality of remaining hair, it is not a miracle fix. It is used only in specific, medically supervised settings, such as menopausal hormone therapy or gender-affirming care, and only after a doctor has weighed the risks.

User Experiences: Why Estradiol Is Used to Treat Hair Loss in Women and Transgender People

Estradiol, a form of estrogen, is part of menopausal hormone therapy and feminizing hormone therapy. Some Tressless community users report less hair loss while on estradiol, usually alongside medicines that lower testosterone or block androgens. These are personal reports, not controlled evidence.

Some women with high androgen levels or polycystic ovary syndrome (PCOS) describe using estrogen-containing treatment under a doctor's care. Some users report less facial and body hair and better scalp hair density after estradiol was added to their treatment. These are personal reports and cannot show that estradiol caused the change.

For transgender women, estradiol is foundational in hormone replacement therapy (HRT). Some community members describe their hairline shifting toward a more female-typical pattern on hormone therapy; published evidence for this is limited to a single case report (Stevenson et al., 2016). Community members report that this effect seemed stronger when estradiol is combined with anti-androgens such as spironolactone or cyproterone acetate. One community post discussed improved hair density and halted recession over time with consistent estradiol dosing, though results vary depending on dose, age, and baseline hair loss.

Some male users have discussed applying estradiol to the scalp, including by mesotherapy (injections into the scalp), hoping to avoid whole-body effects. Commenters warned that estradiol applied to or injected into the skin can still enter the bloodstream. Estradiol is not approved for hair loss, there is no evidence that local use in men works or is safe, and in men it can cause breast growth and other feminizing changes. Other users report higher estradiol levels while taking finasteride, and some men described mood changes and breast tenderness. These are individual reports and do not show that estradiol caused the symptoms. Breast lumps, pain, swelling or nipple discharge while taking finasteride should be checked by a doctor; the US Propecia label lists male breast cancer among postmarketing reports. The UK regulator (MHRA, May 2026) advises stopping finasteride 1 mg immediately and contacting a doctor if depression or suicidal thoughts develop.

Research in transgender women has mostly measured hormone levels, not hair. A clinic study of transgender women on oral estradiol found wide variation in the dose each person needed to reach target hormone levels; nearly a third did not reach their goals even at the highest doses used, and finasteride use was linked to higher testosterone levels (Leinung et al., 2018). The study did not measure hair.

One community post described a trans woman who developed a meningioma (a usually benign brain tumour) after nine years on cyproterone acetate and estradiol. Cyproterone acetate, often used alongside estradiol, carries a meningioma risk that rises with the total dose taken. Since 2020 the European Medicines Agency has advised that cyproterone at 10 mg a day or more be used for conditions such as hair loss only after other treatments have failed (EMA, 2020).

In conclusion, community reports and limited, uncontrolled research suggest estradiol may help some women and trans people within supervised hormone therapy. However, results are variable, systemic side effects are real, and medical supervision is critical. While some users report success, usually in combination with anti-androgens, the experience depends heavily on dosing strategy, co-treatments, and individual hormone sensitivity.

References

Bedair, N. I., El-Komy, M. H. M., Mohamed, R. E., Shamma, R. N., & Amer, M. A. (2025). Efficacy and safety of combined topical estradiol with minoxidil vs. topical minoxidil in female pattern hair loss: a trichoscopic randomized controlled trial. Clinical and Experimental Dermatology, 50(3), 611–619. https://pubmed.ncbi.nlm.nih.gov/39412172/

European Medicines Agency. (2020, February 14). Restrictions in use of cyproterone due to meningioma risk (EMA/70255/2020). https://www.ema.europa.eu/en/documents/press-release/restrictions-use-cyproterone-due-meningioma-risk_en.pdf

Estradiol tablets, USP. Prescribing information (boxed warning and contraindications). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5718f042-e8c0-b721-e063-6294a90a5bef

Evamist (estradiol transdermal spray). Prescribing information (unintentional secondary exposure). DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a0aa631-133d-406b-9d32-8a1a99af4e50

Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal treatment of transgender women with oral estradiol. Transgender Health, 3(1), 74–81. https://pubmed.ncbi.nlm.nih.gov/29756046/

Stevenson, M. O., Wixon, N., & Safer, J. D. (2016). Scalp hair regrowth in hormone-treated transgender woman. Transgender Health, 1(1), 202–204. https://pubmed.ncbi.nlm.nih.gov/28861534/

Thornton, M. J., Taylor, A. H., Mulligan, K., Al-Azzawi, F., Lyon, C. C., O'Driscoll, J., & Messenger, A. G. (2003). Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Experimental Dermatology, 12(2), 181–190. https://pubmed.ncbi.nlm.nih.gov/12702147/

van Zuuren, E. J., Fedorowicz, Z., & Carter, B. (2012). Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. British Journal of Dermatology, 167(5), 995–1010. https://doi.org/10.1111/j.1365-2133.2012.11166.x

Reddit. (2024, Nov 29). Estradiol mesotherapy / idea feedback. Retrieved from https://reddit.com/r/tressless/comments/1h2q1cb/estradiol_mesotherapy_idea_feedback

Reddit. (2025, Jun 09). My Estradiol Level on Finasteride. Retrieved from https://reddit.com/r/tressless/comments/1l76tt8/my_estradiol_level_on_finasteride/

Reddit. (2024, Oct 07). Finasteride has increased my Estradiol (estrogen) levels by 51%. Retrieved from https://reddit.com/r/tressless/comments/1fy8p48/finasteride_has_increased_my_estradiol_estrogen/

Reddit. (2025, Apr 06). Hypothetically, if estradiol has been a "cure" for hair loss.... Retrieved from https://reddit.com/r/tressless/comments/1jsn2nz/hypothetically_if_estradiol_has_been_a_cure_for/